R A Heyman Selected Research

R A Heyman Research Topics

3	Insulin Resistance 08/2001 - 04/2000
2	Atherosclerosis 02/2001 - 08/2000
2	Neoplasms (Cancer) 08/2000 - 04/2000
1	Type 2 Diabetes Mellitus (MODY) 06/2003
1	Hyperglycemia 04/2001
1	Hypertriglyceridemia 02/2001
1	Obesity 08/2000
1	Body Weight (Weight, Body) 08/2000
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2000
1	Squamous Cell Carcinoma of Head and Neck 04/2000

6	Retinoid X Receptors (Retinoid X Receptor)IBA 06/2003 - 04/2000
3	Insulin (Novolin)FDA Link 06/2003 - 04/2000
2	LG 100268IBA 04/2001 - 08/2000
2	Rosiglitazone (Avandia)FDA Link 04/2001 - 08/2000
2	PPAR gammaIBA 04/2001 - 08/2000
2	RetinoidsIBA 02/2001 - 04/2000
1	AcidsIBA 06/2003
1	LG 100754IBA 08/2001
1	CholesterolIBA 02/2001
1	ApolipoproteinsIBA 02/2001
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 02/2001
1	Heparin (Liquaemin)FDA LinkGeneric 02/2001
1	LG 268IBA 02/2001
1	VLDL LipoproteinsIBA 02/2001
1	Triglycerides (Triacylglycerol)IBA 02/2001
1	Blood Glucose (Blood Sugar)IBA 08/2000
1	Glucose (Dextrose)FDA LinkGeneric 08/2000
1	LG 100324IBA 08/2000
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2000
1	LipidsIBA 04/2000
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2000
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 04/2000

1	Therapeutics 04/2000
1	Chemoprevention 04/2000